Prevalence of hepatitis B virus infection in Japanese patients with HIV

Hepatology Research

Volumn 38, Issue 3, 2008, Pages 310-314

  Koike, Kazuhiko ^a   Kikuchi, Yoshimi ^b   Kato, Michio ^c   Takamatsu, Junki ^d   Shintani, Yoshizumi ^a   Tsutsumi, Takeya ^a   Fujie, Hajime ^a   Miyoshi, Hideyuki ^a   Moriya, Kyoji ^a   Yotsuyanagi, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

^d NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Co infection; Hepatitis B; HIV; Liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; JAPANESE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SUPERINFECTION; VIRUS TRANSMISSION;

EID: 38849160946     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00263.x     Document Type: Article

References (17)

1. Alter MJ. Epidemiology of viral hepatitis and HIV coinfection. J Hepatol 2006; 44: S6-9.
2. Sherman KE, Peters M, Koziel MJ. HIV and liver disease forum: Conference proceedings. Hepatology 2007; 45: 1566-77.
3. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007; 7: 402-9.
4. Maida I, Soriano V, Castellares C et al. Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity. HIV Clin Trials 2006; 7: 246-50.
5. Bica I, McGovern B, Dhar R et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32: 492-7.
6. Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations: A review of epidemiology and prevention. AIDS 2005; 19: S41-6.
7. Salmon-Ceron D, Lewden C, Morlat P et al. Liver disease as a major cause of death among HIV infected patients: Role of hepatitis C and B viruses and alcohol. J Hepatol 2005; 42: 799-805.
8. Ozasa A, Tanaka Y, Orito E et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 2006; 44: 326-34.
9. Thio CL, Locarnini S. Treatment of HIV/HBV coinfection: Clinical and virologic issues. AIDS Rev 2007; 9: 40-53.
10. Sulkowski MS. Hepatotoxicity associated with antiretroviral therapy containing HIV-1 protease inhibitors. Semin Liver Dis 2003; 23: 183-94.
11. Jain MK, Comanor L, White C et al. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: Factors associated with response. J Viral Hepat 2007; 14: 176-82.
12. Quarleri J, Moretti F, Bouzas MB et al. Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B. AIDS Res Hum Retroviruses 2007; 23: 525-31.
13. Tatsunami S, Taki M, Shirahata A, Mimaya J, Yamada K. Increasing incidence of critical liver disease among causes of death in Japanese hemophiliacs with HIV-1. Acta Haematol 2004; 111: 181-4.
14. The Ministry of Health, Labor and Welfare of Japan. National AIDS Survey Report, 2004. [Cited 2007.]Available from URL: http://www.wam.go.jp/ wamappl/bb14GS50.nsf/vAdmPBigcategory40/ 727FDBF7F51718B5492572C800071D25?OpenDocument
15. Tanaka J, Kumagai J, Katayama K et al. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 34856 48 first-time blood donors during 1995-2000. Intervirology 2004; 47: 32-40.
16. Koike K, Tsukada K, Yotsuyanagi H et al. Prevalence of coinfection with human immunodeficiency virus and hepatitis C virus in Japan. Hepatol Res 2007; 37: 2-5.
17. Denis F, Adjide CC, Rogez S, Delpeyroux C, Rogez JP, Weinbreck P. Seroprevalence of HBV, HCV and HDV hepatitis markers in 500 patients infected with the human immunodeficiency virus. Pathol Biol (Paris) 1997; 45: 701-8.